The investigational oral therapy combines doravirine, a non-nucleoside reverse transcriptase inhibitor, with islatravir, a nucleoside reverse transcriptase translocation inhibitor, in a single tablet ...

Agios Pharmaceuticals plans to share data from RISE UP with the Food and Drug Administration to support the approval of the sickle cell disease indication.

Study reveals self-administered, at-home hypnosis intervention reduces mean number of hot flashes, daily interference.

Lung ultrasound is acceptable diagnostic alternative to chest radiography in medical centers with appropriate clinical expertise.